Is all-rac-α-tocopherol different from RRR-α-tocopherol regarding cardiovascular efficacy? A meta-analysis of clinical trials

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 435-438

  Kraemer, Klaus ^a   Koch, W ^a   Hoppe, P P ^a  

^a BASF SE   (Germany)

Author keywords

all rac tocopherol; Cardiovascular system; Meta analysis; RRR tocopherol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL;

CARDIOVASCULAR PERFORMANCE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; EVALUATION; HUMAN; META ANALYSIS; PUBLICATION; RACEMIC MIXTURE; SAFETY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITAMIN INTAKE;

EID: 14944381217     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.066     Document Type: Conference Paper

References (5)

1. JIALAL, I. & S. DEVARAJ. 2003. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107: 926-928.
2. BROCKWELL, S. & I. GORDON. 2001. A comparison of statistical methods for meta-analysis. Statistics in Medicine 20: 825-840
3. SANO, M. et al. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336: 1216-1222.
4. AGE-RELATED EYE DISEASE STUDY RESEARCH GROUP. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS Report No. 9. Arch. Ophthalmol. 119: 1439-1452.
5. WATERS, D.D. et al. 2002. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288: 2432-2440.